These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10516499)

  • 1. Effect of oral adsorbent AST-120 on plasma metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 concentrations in chronic renal failure.
    Ebihara I; Nakamura T; Ushiyama C; Suzuki S; Shimada N; Koide H
    Nephron; 1999; 83(2):169. PubMed ID: 10516499
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
    Yoshida Y; Sakai T; Asakura K; Sugano M; Ise M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1001-8. PubMed ID: 2263021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure.
    Ueda S; Yamagishi S; Takeuchi M; Kohno K; Shibata R; Matsumoto Y; Kaneyuki U; Fujimura T; Hayashida A; Okuda S
    Mol Med; 2006; 12(7-8):180-4. PubMed ID: 17088950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein].
    Niimura F; Ise M; Uehara Y; Kumano K; Sakai T
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):261-71. PubMed ID: 1630028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.
    Gerlach RF; Tanus-Santos JE
    Am Heart J; 2006 Jul; 152(1):e9. PubMed ID: 16824824
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach.
    Makrakis E; Grigoriou O; Kouskouni E; Vitoratos N; Salamalekis E; Chatzoudi E; Creatsas G
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):170-6. PubMed ID: 14694972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats.
    Tan X; He J; Cao X; Zou J; Liu H; Ding X
    Ren Fail; 2015 Mar; 37(2):337-42. PubMed ID: 25426870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
    Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
    Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Mult Scler; 2006 Feb; 12(1):120. PubMed ID: 16459731
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Shimada N; Ebihara I; Koide H
    Kidney Blood Press Res; 2004; 27(2):121-6. PubMed ID: 15051932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Clin Neurol Neurosurg; 2006 Sep; 108(6):617-8; author reply 618. PubMed ID: 16413675
    [No Abstract]   [Full Text] [Related]  

  • 15. Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
    Bertsch T; Sueselbeck T; Wolpert C; Hoffmann U; Kaden JJ; Haase KK; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2005; 43(6):660-3. PubMed ID: 16006264
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum or plasma: what kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?
    Jung K
    J Neuroimmunol; 2005 May; 162(1-2):1-2. PubMed ID: 15833353
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats.
    Aoyama I; Shimokata K; Niwa T
    Am J Nephrol; 2000; 20(3):232-41. PubMed ID: 10878408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating sampling methods for measurement of circulating matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1.
    Zhang RY; Cui W; Zhao KJ; Tang YQ; Li L
    Pancreas; 2010 Aug; 39(6):937; author reply 937-8. PubMed ID: 20664481
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.
    Korematsu S; Ohta Y; Tamai N; Takeguchi M; Goto C; Miyahara H; Kawano T; Izumi T
    Pediatr Infect Dis J; 2012 Sep; 31(9):973-4. PubMed ID: 22895216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an oral adsorbent on cisplatin-induced nephropathy in rats.
    Sato T; Miyazaki S; Mohri S
    Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):290-5. PubMed ID: 8741389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.